Drugs as P-glycoprotein substrates, inhibitors, and inducers

被引:295
作者
Kim, RB
机构
[1] Vanderbilt Univ, Sch Med, Dept Med, Div Clin Pharmacol, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Sch Med, Dept Pharmacol, Div Clin Pharmacol, Nashville, TN 37232 USA
关键词
D O I
10.1081/DMR-120001389
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
[No abstract available]
引用
收藏
页码:47 / 54
页数:8
相关论文
共 57 条
  • [1] Biochemical, cellular, and pharmacological aspects of the multidrug transporter
    Ambudkar, SV
    Dey, S
    Hrycyna, CA
    Ramachandra, M
    Pastan, I
    Gottesman, MM
    [J]. ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1999, 39 : 361 - 398
  • [2] Aquilante CL, 1999, LIFE SCI, V66, pPL47
  • [3] Steroid transport, accumulation, and antagonism of P-glycoprotein in multidrug-resistant cells
    Barnes, KM
    Dickstein, B
    Cutler, GB
    Fojo, T
    Bates, SE
    [J]. BIOCHEMISTRY, 1996, 35 (15) : 4820 - 4827
  • [4] Atorvastatin coadministration may increase digoxin concentrations by inhibition of intestinal P-glycoprotein-mediated secretion
    Boyd, RA
    Stern, RH
    Stewart, BH
    Wu, XC
    Reyner, EL
    Zegarac, EA
    Randinitis, EJ
    Whitfield, L
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 40 (01) : 91 - 98
  • [5] CALLAGHAN R, 1993, J BIOL CHEM, V268, P16059
  • [6] Choo EF, 2000, DRUG METAB DISPOS, V28, P655
  • [7] Chu XY, 1999, DRUG METAB DISPOS, V27, P440
  • [8] Collett A, 1999, J PHARMACOL EXP THER, V288, P171
  • [9] Secretion of sparfloxacin from the human intestinal Caco-2 cell line is altered by P-glycoprotein inhibitors
    Cormet-Boyaka, E
    Huneau, JF
    Mordrelle, A
    Boyaka, PN
    Carbon, C
    Rubinstein, E
    Tomé, T
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (10) : 2607 - 2611
  • [10] Cvetkovic M, 1999, DRUG METAB DISPOS, V27, P866